- Filed
- Aug 19, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 19, 2024 | 8.06M sh |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $1.5M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $2.05M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $2.07M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $1.93M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $2.94M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $2.83M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $6.23M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $4.85M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $8.44M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $7.29M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 8.01M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 7.87M sh |
| Stock Repurchased | Q2 2024 · Jun 30, 2023 | $0 |
| Capex | Q2 2024 · Jun 30, 2023 | $0 |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $79.5K |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $3.66M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $3.47M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $3.37M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.01 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.03 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.01 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.03 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $341.94K |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $651.95K |
| Net Income | Q2 2024 · Jun 30, 2023 | $57.17K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$237.75K |
| Net Income | Q2 2024 · Mar 31, 2023 | −$294.93K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$67.37K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$486.9K |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $944.65K |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $1.8M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $3.19M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $6.14M |
| Revenue | Q2 2024 · Jun 30, 2023 | $4.13M |
| Revenue | Q2 2024 · Jun 30, 2023 | $7.94M |